Dr. Mukhopadhyay is Associate Professor of Pathology and Director of Pulmonary Pathology at the Cleveland Clinic and Associate Editor (Pulmonary) of the American Journal of Clinical Pathology. He attended medical school in India and completed pathology residency training at the All India Institute of Medical Sciences followed by a second pathology residency at SUNY Upstate Medical University in Syracuse, NY. His interests include granulomatous lung diseases, including infections, interstitial lung disease, and lung cancer. The pulmonary pathology service at Cleveland Clinic signs out 5000 cases a year and supports a large group of ILD pulmonologists and several thoracic surgeons.
Dr. Mukhopadhyay has authored more than 100 publications in indexed, peer-reviewed journals, and is the author of a lung pathology textbook published by Cambridge University Press in 2016. His studies have been published in the American Journal of Surgical Pathology, American Journal of Clinical Pathology, Modern Pathology, Human Pathology, Archives of Pathology and Laboratory Medicine, Chest and Thorax. In 2011, he was invited to join the faculty of the prestigious USCAP Long Course in Pulmonary Pathology. He has received several teaching awards, served on the abstract review committees of the USCAP and CAP for several years, and taught two USCAP Short Courses.
Since 2016, he has pioneered the use of online platforms for teaching lung pathology globally, for which The Pathologist magazine named him to its “Power List” from 2018 to 2020. In 2018, Dr. Mukhopadhyay first-authored a landmark study that led to FDA approval for whole slide imaging for primary diagnosis in surgical pathology in the United States. This was followed by two highly cited studies of the effects of vaping on the lung and autopsy findings in COVID-19 that have generated intense interest in the national news media and online. Dr. Mukhopadhyay was recently featured in a New York Times video on COVID-19 and ARDS that has been viewed more than 1.7 million times.